Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States, in Australia, in New Zealand, .... It is testing KarXT for manic episodes in bipolarity type I.
Multiple locations, including BentonvilleThis study is recruiting in the United States, in Croatia, in India, .... It is testing KarXT for manic episodes in bipolarity type I.
Multiple locations, including Little RockThis study is recruiting in the United States, in Argentina, in Colombia, .... It is testing KarXT for schizophrenia.
Multiple locations, including AnaheimThis study is recruiting in Japan. It is testing KarXT for schizophrenia.
Multiple locations, including KōnanThis study is recruiting in the United States, in Bulgaria, in Czech Republic, .... It is testing SPT-300 (GlyphAllo) for depression.
Multiple locations, including ChinoThis study is recruiting in the United States. It is testing Efficacy of AXS-05 Compared to Bupropion for depression.
Multiple locations, including BellflowerThis study is recruiting in China. It is testing Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray for depression.
Multiple locations, including BeijingThis study is recruiting in the United States, in France, in Canada, .... It is testing KarXT and KarX-EC for schizophrenia.
Multiple locations, including AnaheimThis study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.
Multiple locations, including Oceanside
This study is recruiting in the United Kingdom. It is testing NTX-1955 for anxiety.
In United KingdomThis study is recruiting in the United States. It focuses on Schizophrenia.
Multiple locations, including Los AlamitosThis study is recruiting in the United States. It is testing TNX-102 SL Monotherapy for depression.
Multiple locations, including Phoenix